Postoperative Adjuvant Treatment Strategy for Locally Advanced Rectal Cancer after Neoadjuvant Treatment

<div>Forest plot based on survival outcomes. (a) Disease-free survival (DFS) in oxaliplatin/fluorouracil- (OX/FU-) based group versus fluorouracil- (FU-) based group; (b) DFS in chemotherapy group versus observation group; (c) overall survival (OS) in chemotherapy group versus observation group; (d) OS in OX/FU-based group versus FU-based group.</div>

BioMed Research International

fig2

Figure 2

Figure 2: Postoperative Adjuvant Treatment Strategy for Locally Advanced Rectal Cancer after Neoadjuvant Treatment 